rs762463914
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_ModeratePS1_ModeratePM2PP5_Very_Strong
The NM_020166.5(MCCC1):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000623 in 1,604,078 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_020166.5 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCCC1 | NM_020166.5 | c.1A>G | p.Met1? | start_lost | Exon 1 of 19 | ENST00000265594.9 | NP_064551.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000179 AC: 4AN: 224070Hom.: 0 AF XY: 0.0000245 AC XY: 3AN XY: 122518
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1451926Hom.: 0 Cov.: 30 AF XY: 0.00000277 AC XY: 2AN XY: 721560
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74312
ClinVar
Submissions by phenotype
3-methylcrotonyl-CoA carboxylase 1 deficiency Pathogenic:3
- -
This sequence change affects the initiator methionine of the MCCC1 mRNA. The next in-frame methionine is located at codon 39. This variant is present in population databases (rs762463914, gnomAD 0.02%). Disruption of the initiator codon has been observed in individual(s) with 3-methylcrotonyl-CoA carboxylase deficiency and/or elevated 3-methylcrotonylglycine (internal data). ClinVar contains an entry for this variant (Variation ID: 542951). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
MCCC1-related disorder Pathogenic:1
The MCCC1 c.1A>G variant is predicted to disrupt the translation initiation site (Start loss). This variant was reported along with an MCCC1 frameshift variant in an individual with abnormal newborn screen results suggestive of 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency (Kim et al. 2017. https://doi.org/10.5734/JGM.2017.14.1.23). To our knowledge, no other variants that disrupt the start codon have been reported in the literature. This variant and another (c.2T>C, p.Met1Thr) that are predicted to disrupt the start codon have been reported in ClinVar and interpreted as likely pathogenic based on internal laboratory data (https://www.ncbi.nlm.nih.gov/clinvar/variation/542951/; https://www.ncbi.nlm.nih.gov/clinvar/variation/1066544/). This variant is reported in 0.023% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-182817228-T-C). This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at